Target intelligence / Profile preview

Vanillyl-alcohol oxidase (VAO)

Target
VAO
Molecular classification
Enzyme, Oxidoreductase, Flavoenzyme
01

Overview

Vanillyl-alcohol oxidase (VAO) is a flavoprotein oxidoreductase that primarily catalyzes the oxidation of vanillyl alcohol and a broad range of other substituted phenolic alcohols to their corresponding aldehydes, with simultaneous reduction of molecular oxygen to hydrogen peroxide[6][7][5][1]. It is a homo-octameric enzyme found in organisms such as *Penicillium simplicissimum* and belongs to the VAO/PCMH family of flavoenzymes[4][1]. VAO uses a firmly bound FAD cofactor for redox catalysis, showing a preference for para-substituted phenols and comprising a unique substrate specificity compared to other aryl alcohol oxidases[3][5][1]. The enzyme is of interest in biotechnology for the biosynthesis of vanillin and fine chemicals, but does not have a direct therapeutic application or known disease linkage in humans[1][6][7]. Its physiological substrate is presumed to be 4-(methoxymethyl)phenol, and it has been structurally characterized by several crystal structures[5][6]. VAO participates in pathways such as degradation of aromatic compounds, e.g., 2,4-dichlorobenzoate[6].

Other names
4-hydroxy-2-methoxybenzyl alcohol oxidasevanillyl alcohol:oxygen oxidoreductase
02

Mechanism of action

Catalyzes the oxidation of vanillyl alcohol and related compounds to their corresponding aldehydes, using FAD as a cofactor and molecular oxygen as the electron acceptor, producing hydrogen peroxide[5][6][7][1]

03

Biological functions

Oxidation of aromatic alcoholsMetabolism of phenolic compoundsParticipation in degradation of environmental pollutantsHydrogen peroxide generation
04

Disease associations

Other (primarily used in biotechnology and industrial biocatalysis rather than human disease)
05

Safety considerations

Potential risks relate to hydrogen peroxide formation (reactive oxygen species)not reported as a therapeutic risk

Beyond the preview

Go deeper on Vanillyl-alcohol oxidase (VAO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vanillyl-alcohol oxidase (VAO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call